Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Weatherald

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|November 27, 2022
The evolving landscape of pulmonary arterial hypertension clinical trialsJason Weatherald, Athénaïs Boucly, Anthony Peters, et al.
Plos One|May 6, 2026
Impact of the COVID-19 pandemic on sex-related disparities in cystic fibrosis healthcare utilization and outcomes: A population studyJason Weatherald, Chuan Wen, Heather Sharpe, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 17, 2017
Acute decompensated pulmonary hypertensionLaurent Savale, Jason Weatherald, Xavier Jaïs, et al.
The European Respiratory Journal|September 11, 2017
Are indexed values better for defining exercise pulmonary hypertension?Jason Weatherald, Athénaïs Boucly, Edmund Lau, et al.
Plos One|May 2, 2025
Living with cystic fibrosis during the COVID-19 pandemic: An interpretive description of healthcare access from patients with cystic fibrosis and their providers in Alberta, CanadaKatelyn Brehon, Pam Hung, Maxi Miciak, et al.
Chest|January 4, 2026
Young chronic e-cigarette users display cardiopulmonary abnormalities during exercise and blunted recruitment of pulmonary diffusing capacityThomas G Williams, Sophie É Collins, Andrew R Brotto, et al.
Annals of the American Thoracic Society|May 31, 2024
Impact of COVID-19 Pandemic on Chronic Obstructive Pulmonary Disease Healthcare Use, Exacerbations, and Mortality: A Population StudyGrace Y Lam, Chuan Wen, Paul E Ronksley, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|April 24, 2024
Increased Virtual Visits to Physicians During the COVID-19 Pandemic and Estimated Impact on Physician Compensation: The Case of Lung and Colorectal Cancers, Chronic Obstructive Pulmonary Diseases, and Heart Failure in Alberta, CanadaNguyen Xuan Thanh, Arianna Waye, Douglas Stewart, et al.
CJC Open|March 2, 2026
Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in CanadaJason Weatherald, Steeve Provencher, Jillian Murray, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 3, 2023
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipientsVardhil Ghandi, David Li, Justin Weinkauf, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|November 27, 2022
The evolving landscape of pulmonary arterial hypertension clinical trialsJason Weatherald, Athénaïs Boucly, Anthony Peters, et al.
Plos One|May 6, 2026
Impact of the COVID-19 pandemic on sex-related disparities in cystic fibrosis healthcare utilization and outcomes: A population studyJason Weatherald, Chuan Wen, Heather Sharpe, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 17, 2017
Acute decompensated pulmonary hypertensionLaurent Savale, Jason Weatherald, Xavier Jaïs, et al.
The European Respiratory Journal|September 11, 2017
Are indexed values better for defining exercise pulmonary hypertension?Jason Weatherald, Athénaïs Boucly, Edmund Lau, et al.
Plos One|May 2, 2025
Living with cystic fibrosis during the COVID-19 pandemic: An interpretive description of healthcare access from patients with cystic fibrosis and their providers in Alberta, CanadaKatelyn Brehon, Pam Hung, Maxi Miciak, et al.
Chest|January 4, 2026
Young chronic e-cigarette users display cardiopulmonary abnormalities during exercise and blunted recruitment of pulmonary diffusing capacityThomas G Williams, Sophie É Collins, Andrew R Brotto, et al.
Annals of the American Thoracic Society|May 31, 2024
Impact of COVID-19 Pandemic on Chronic Obstructive Pulmonary Disease Healthcare Use, Exacerbations, and Mortality: A Population StudyGrace Y Lam, Chuan Wen, Paul E Ronksley, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|April 24, 2024
Increased Virtual Visits to Physicians During the COVID-19 Pandemic and Estimated Impact on Physician Compensation: The Case of Lung and Colorectal Cancers, Chronic Obstructive Pulmonary Diseases, and Heart Failure in Alberta, CanadaNguyen Xuan Thanh, Arianna Waye, Douglas Stewart, et al.
CJC Open|March 2, 2026
Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in CanadaJason Weatherald, Steeve Provencher, Jillian Murray, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 3, 2023
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipientsVardhil Ghandi, David Li, Justin Weinkauf, et al.
Pageof 16